language |
eng
|
Author |
Horimatsu Takahiro
Department of Therapeutic Oncology, Kyoto University Hospital, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
Nakayama Norisuke
Department of Gastroenterology, Kanagawa Cancer Center, Kanazawa, Japan
Moriwaki Toshikazu
Division of Gastroenterology, University of Tsukuba, Tsukuba, Japan
Hirashima Yoshinori
Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan
Fujita Mikio
Department of Gastroenterology and Hepetology, Kobe City Medical Center General Hospital, Kobe, Japan
Asayama Masako
Department of Gastroenterology, Saitama Cancer Center Hospital, Saitama, Japan
Nakashima Koji
First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Baba Eishi
Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Kitamura Hiroshi
Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
Tamura Takao
Department of Medical Oncology, Faculty of Medicine, Kinki University, Higashiosaka, Japan
Hosokawa Ayumu
Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, Toyama, Japan
Yoshimura Kenichi
Innovative Clinical Research Center (ICREK), Kanazawa University Hospital, Kanazawa, Japan
Muto Manabu
Department of Therapeutic Oncology, Kyoto University Hospital, 54, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan
|
Subject | Adenocarcinoma; Chemotherapy; mFOLFOX6; Immunochemical analysis; Oxaliplatin; Small bowel
|
Journal Title |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
|
Volume | 22
|
Issue | 5
|
Start Page | 905
|
End Page | 912
|
ISSN | 1341-9625
|
ISSN(Online) | 1437-7772
|
Published Date | 2017-10
|
DOI | |
PubMed ID | |
Publisher | SPRINGER JAPAN KK
|
NII Type |
Journal Article
|
OAI-PMH Set |
Faculty of Medicine
|